BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20026524)

  • 1. Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement.
    Iizuka N; Okamoto K; Matsushita R; Kimura M; Nagai K; Arito M; Kurokawa MS; Masuko K; Suematsu N; Hirohata S; Kato T
    Lupus; 2010 May; 19(6):717-26. PubMed ID: 20026524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
    Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus.
    Ndhlovu M; Preuss BE; Dengjel J; Stevanovic S; Weiner SM; Klein R
    Brain Behav Immun; 2011 Feb; 25(2):279-85. PubMed ID: 20884345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI.
    Kimura A; Sakurai T; Tanaka Y; Hozumi I; Takahashi K; Takemura M; Saito K; Seishima M; Inuzuka T
    Lupus; 2008 Jan; 17(1):16-20. PubMed ID: 18089678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of anti- ubiquitin C-terminal hydrolase L1 autoantibodies in the diagnosis of neuropsychiatric systemic lupus erythematosus].
    Meng Y; Sun H; Xu JJ; Li R; Wang Y
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(42):3316-3319. PubMed ID: 29141377
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches.
    Katsumata Y; Kawaguchi Y; Baba S; Hattori S; Tahara K; Ito K; Iwasaki T; Yamaguchi N; Oyama M; Kozuka-Hata H; Hattori H; Nagata K; Yamanaka H; Hara M
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.005330. PubMed ID: 21474795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
    Zhang X; Shu H; Zhang F; Tian X; Dong Y
    Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases.
    Delunardo F; Soldati D; Bellisario V; Berry A; Camerini S; Crescenzi M; Alessandri C; Conti F; Ceccarelli F; Francia A; Valesini G; Cirulli F; Siracusano A; Siracusano A; Niolu C; Alex Rubino I; Ortona E; Margutti P
    Arthritis Rheumatol; 2016 Nov; 68(11):2708-2716. PubMed ID: 27213890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
    Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
    Williams S; Sakic B; Hoffman SA
    J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profiling reveals four protein candidate autoantigens associated with systemic lupus erythematosus.
    Frostegård J; Hellström C; Nilsson P; Frostegård AG; Ajeganova S
    Lupus; 2018 Sep; 27(10):1670-1678. PubMed ID: 30041579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus.
    van der Meulen PM; Barendregt AM; Cuadrado E; Magro-Checa C; Steup-Beekman GM; Schonenberg-Meinema D; Van den Berg JM; Li QZ; Baars PA; Wouters D; Voskuyl AE; Ten Berge IRJM; Huizinga TWJ; Kuijpers TW
    Rheumatology (Oxford); 2017 Aug; 56(8):1407-1416. PubMed ID: 28460084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.
    Karasawa R; Kurokawa MS; Yudoh K; Masuko K; Ozaki S; Kato T
    Clin Exp Immunol; 2010 Sep; 161(3):459-70. PubMed ID: 20646000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
    Hu C; Huang W; Chen H; Song G; Li P; Shan Q; Zhang X; Zhang F; Zhu H; Wu L; Li Y
    PLoS One; 2015; 10(5):e0126643. PubMed ID: 25954975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to new cytoplasmic autoantigens: anti-JA, a potential marker for disease activity in systemic lupus erythematosus.
    Bonfa E; Tavares AV; Viana VS; Levy-Neto M; Kumeda CA; Cossermelli W
    Braz J Med Biol Res; 1992; 25(6):601-9. PubMed ID: 1342236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.